Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction
Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter.
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion.
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion.
Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction
Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter.
Latest beat-and-raise boosts Rolls-Royce, one of Europe’s hottest stocks
Shares of Rolls-Royce surged on Thursday, as the engine maker’s latest beat-and-raise buoyed one of Europe’s hottest stocks.
Shell beats expectations as cost-cutting plans boost profitability
The British energy giant increased its profits in the face of lower oil and gas prices, as it successfully cut its costs by $700 million...
Telegram unveils in-app browser for decentralized websites
Telegram’s in-app browser will support decentralized websites built on the TON blockchain. Users can have access to games and services within the mini apps, with...
Volkswagen’s profits slump in face of mounting competition from China
The world’s largest carmaker was hit by a slump in sales in its largest market China driven by intense competition from domestic rivals
‘The most magical property I’ve ever seen’: Tom Petty’s charming Malibu compound to be listed at $19 million
The SoCal home of the late musician sits on 2 acres and includes a recording studio and a stately fireplace that Petty himself renovated.